Results 271 to 280 of about 271,092 (363)

Potentials and practical challenges of terbium-161 labeled radiopharmaceuticals. [PDF]

open access: yesEJNMMI Radiopharm Chem
Ntihabose CM   +11 more
europepmc   +1 more source

The development and application of the stirred‐reactor coupon analysis (SRCA) test method

open access: yesInternational Journal of Applied Glass Science, Volume 16, Issue 4, October 2025.
Abstract A new technique, termed the stirred‐reactor coupon analysis (SRCA) method, has been developed to measure the rate of glass dissolution in forward‐rate conditions. Monolithic glass coupons are partially masked with an inert material before placement in a large volume of well‐mixed solution with known chemistry and temperature for a ...
Joelle T. Reiser   +28 more
wiley   +1 more source

Impact of Different Modalities of Radiotherapy in Locally Advanced Pancreatic Cancer: A Review and Meta‐Analysis

open access: yesJournal of Gastroenterology and Hepatology, Volume 40, Issue 10, Page 2413-2424, October 2025.
ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) remains a high‐mortality cancer in dire need of more effective therapeutic strategies. Six randomized controlled trials have compared chemotherapy with chemoradiotherapy in patients with locally advanced pancreatic cancer (LAPC), but these trials only involved conventional external beam radiotherapy ...
Amanda H. Lim   +6 more
wiley   +1 more source

Establishing measurement traceability for quantitative SPECT imaging. [PDF]

open access: yesEJNMMI Phys
Robinson AP   +8 more
europepmc   +1 more source

Association rule mining of clinical and biomarker data in neuroendocrine tumors: A prospective study on disease progression

open access: yesJournal of Neuroendocrinology, Volume 37, Issue 10, October 2025.
Abstract There is an unmet need for new methods to predict disease course in patients with neuroendocrine tumors (NET). We investigated 92 putative cancer‐related plasma proteins including chromogranin A (CgA) and clinical parameters at the time of diagnosis to identify early factors associated with progressive (PD) or stable disease (SD).
Ulrich Peter Knigge   +9 more
wiley   +1 more source

Impact on symptoms and survival of bone metastases in patients with small‐intestinal neuroendocrine tumours

open access: yesJournal of Neuroendocrinology, Volume 37, Issue 10, October 2025.
Abstract We aimed to assess the symptoms and impact on overall survival (OS) from bone metastases (BM) diagnosed on Gallium‐68‐labelled DOTA tyrosine octreotide positron emission tomography with computed tomography (68Ga‐DOTATOC‐PET/CT) in patients with well‐differentiated small intestinal neuroendocrine tumours (Si‐NETs).
Maria Wedin   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy